Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Fish and Richardson
Deloitte
McKinsey
Novartis
Covington
Johnson and Johnson
Daiichi Sankyo
Baxter
Federal Trade Commission

Generated: January 23, 2018

DrugPatentWatch Database Preview

TACROLIMUS Drug Profile

« Back to Dashboard

Which patents cover Tacrolimus, and what generic alternatives are available?

Tacrolimus is a drug marketed by Accord Hlthcare, Dr Reddys Labs Ltd, Mylan, Panacea Biotec Ltd, Sandoz, Strides Pharma, Watson Labs, Hospira Inc, and Fougera Pharms Inc. and is included in nine NDAs.

The generic ingredient in TACROLIMUS is tacrolimus. There are twenty drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the tacrolimus profile page.
Drug patent expirations by year for TACROLIMUS
Pharmacology for TACROLIMUS
Medical Subject Heading (MeSH) Categories for TACROLIMUS

US Patents and Regulatory Information for TACROLIMUS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare TACROLIMUS tacrolimus CAPSULE;ORAL 091195-001 Aug 31, 2011 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Strides Pharma TACROLIMUS tacrolimus CAPSULE;ORAL 090687-003 Jul 22, 2014 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan TACROLIMUS tacrolimus CAPSULE;ORAL 090596-001 Sep 17, 2010 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Dr Reddys Labs Ltd TACROLIMUS tacrolimus CAPSULE;ORAL 090509-001 May 12, 2010 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Panacea Biotec Ltd TACROLIMUS tacrolimus CAPSULE;ORAL 090802-003 Sep 28, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira Inc TACROLIMUS tacrolimus INJECTABLE;INJECTION 203900-001 Aug 25, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan TACROLIMUS tacrolimus CAPSULE;ORAL 090596-002 Sep 17, 2010 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs TACROLIMUS tacrolimus CAPSULE;ORAL 090402-001 Jul 1, 2010 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Strides Pharma TACROLIMUS tacrolimus CAPSULE;ORAL 090687-001 Jul 22, 2014 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz TACROLIMUS tacrolimus CAPSULE;ORAL 065461-002 Aug 10, 2009 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
QuintilesIMS
Fish and Richardson
Covington
Harvard Business School
McKinsey
UBS
Citi
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot